Sonoma Biotherapeutics
Jason Do has over 20 years of experience in clinical research and took on different roles such as a study coordinator, data manager, clinical research associate, and trial manager for the clinical development of diagnostic, therapeutic, and biologic investigational products. He has managed many clinical programs from Phase 1 through Phase 3, including first in human compounds, proof of concept, and safety and efficacy studies in oncology, ophthalmology, CNS, immunology, gastroenterology and infectious diseases. Prior to joining the Sonoma Bio team, Do worked at San Diego-based CNS company Acadia Pharmaceuticals where he was a Senior Manager of Clinical Operations. Jason graduated from the University of California San Diego where he earned a biology degree in Physiology and Neuroscience.
This person is not in the org chart
This person is not in any offices
Sonoma Biotherapeutics
1 followers
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.